Literature DB >> 23968938

Visual hallucinations and cognitive impairment in Parkinson's disease.

Hee Kyung Park1, Jae Seung Kim, Ki Chun Im, Mi Jung Kim, Jae-Hong Lee, Myoung C Lee, Juhan Kim, Sun Ju Chung.   

Abstract

BACKGROUND: Visual hallucination (VH) is a common psychotic symptom in patients with Parkinson's disease (PD) and may be a significant predictor of cognitive impairment (CI) in such patients.
OBJECTIVE: This study aimed to investigate the pattern of glucose metabolism of VH and the relationship between VH and CI in PD.
METHODS: We studied 28 PD patients, including 15 with VH (PD-VH) and 13 without VH (PD-NVH). Of the 15 PD-VH patients, 8 patients had cognitive impairment (PD-VHCI) whereas 7 did not (PD-VHNCI). All patients underwent [18F] fluorodeoxyglucose positron emission tomography ([18F] FDG PET) followed by statistical parametric mapping (SPM) analyses.
RESULTS: Compared to the patients with PDNVH, PD-VHNCI patients showed glucose hypometabolism in the inferior and middle temporal cortices, fusiform gyri, and frontal areas, suggesting the involvement of the ventral visual pathway. Compared to the patients with PDNVH, PD-VHCI patients showed glucose hypometabolism in the temporoparietal association cortices with scattered frontal areas.
CONCLUSION: Dysfunction of ventral visual pathway involving the temporal lobe may play a key role in VH development in PD patients. The evolving distribution from the ventral visual pathway to more extensive posterior cortices in PD-VHCI patients suggests that VH may be a prodromal symptom occurring prior to CI in PD patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23968938     DOI: 10.1017/s0317167100014888

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  11 in total

1.  Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Authors:  Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton
Journal:  J Clin Exp Neuropsychol       Date:  2019-06-10       Impact factor: 2.475

2.  Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson's Disease.

Authors:  Kelsey A Holiday; Eva Pirogovsky-Turk; Vanessa L Malcarne; J Vincent Filoteo; Irene Litvan; Stephanie L Lessig; David Song; Dawn M Schiehser
Journal:  Mov Disord Clin Pract       Date:  2017-03-16

3.  Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.

Authors:  Carmen Gasca-Salas; Pedro Clavero; David García-García; José A Obeso; María C Rodríguez-Oroz
Journal:  Hum Brain Mapp       Date:  2015-12-14       Impact factor: 5.038

Review 4.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

Review 5.  The psychosis spectrum in Parkinson disease.

Authors:  Dominic H Ffytche; Byron Creese; Marios Politis; K Ray Chaudhuri; Daniel Weintraub; Clive Ballard; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

6.  Automated synthesis of 18F-fluoropropoxytryptophan for amino acid transporter system imaging.

Authors:  I-Hong Shih; Xu-Dong Duan; Fan-Lin Kong; Michael D Williams; Kevin Yang; Yin-Han Zhang; David J Yang
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 7.  Structural and Functional Neuroimaging of Visual Hallucinations in Lewy Body Disease: A Systematic Literature Review.

Authors:  Stefania Pezzoli; Annachiara Cagnin; Oliver Bandmann; Annalena Venneri
Journal:  Brain Sci       Date:  2017-07-15

Review 8.  Structural and Functional Brain Patterns of Non-Motor Syndromes in Parkinson's Disease.

Authors:  Tino Prell
Journal:  Front Neurol       Date:  2018-03-12       Impact factor: 4.003

9.  Aberrant resting-state oscillatory brain activity in Parkinson's disease patients with visual hallucinations: An MEG source-space study.

Authors:  M Dauwan; J I Hoff; E M Vriens; A Hillebrand; C J Stam; I E Sommer
Journal:  Neuroimage Clin       Date:  2019-03-13       Impact factor: 4.881

Review 10.  Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease.

Authors:  Alexandru Hanganu; Oury Monchi
Journal:  Parkinsons Dis       Date:  2016-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.